TrialBreast (Edinburgh, Scotland)2026

Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.

Naruto Taira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.